| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Bienaime Jean Jacques serves as a Director at BMRN and has filed Form 4s across 6 companies. Across recent SEC filings that breaks down to 32 buys and 186 sells. Those positions are worth an estimated $38.3M at current prices.
Historically, Bienaime Jean Jacques's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$36.5M) as Director. The recent filings there lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 20,000 | $81.91 | $1,638,200.00 | -5.6% | +5.3% | +21.2% | |
| Apr 14, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $83.66 | $836,600.00 | -2.9% | +6.2% | +19.4% | |
| Mar 11, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 30,000 | $77.69 | $2,330,700.00 | -8.1% | +0.9% | +19.1% | |
| Jan 13, 2022 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $88.43 | $884,300.00 | -3.2% | -4.7% | +27.9% | |
| Dec 16, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 12,000 | $83.70 | $1,004,340.00 | -3.8% | -3.4% | +30.0% | |
| Dec 1, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sell | 1,500 | $87.22 | $130,831.50 | -0.5% | -8.4% | +21.9% | |
| May 10, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,513 | $77.29 | $657,969.77 | -2.7% | +1.5% | +4.0% | |
| May 7, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 50,000 | $78.21 | $3,910,319.31 | -14.1% | +0.2% | +1.9% | |
| Apr 23, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 20,000 | $79.13 | $1,582,500.00 | -6.2% | -0.3% | +2.2% | |
| Mar 12, 2021 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 14,000 | $77.39 | $1,083,460.00 | -4.5% | +6.7% | -3.1% |